4//SEC Filing
Krempa David 4
Accession 0001437749-25-020518
CIK 0001710340other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:56 PM ET
Size
8.3 KB
Accession
0001437749-25-020518
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Sale
Common Stock
2025-06-12$14.92/sh−16,977$253,297→ 629,669 total - Sale
Common Stock
2025-06-13$14.77/sh−6,800$100,436→ 622,869 total - Sale
Common Stock
2025-06-16$14.73/sh−10,223$150,585→ 612,646 total
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $14.77 to $14.98. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $14.75 to $14.81. The price reported above reflects the weighted average sales price.
- [F3]The shares were sold in multiple trades at prices ranging from $14.50 to $14.79. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001968254
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:56 PM ET
- Size
- 8.3 KB